HIKMA. 503B
LIVE

Serial Number

90795697

Owner

Hikma Injectables USA Inc.

Attorney

MICHELLE E. TOCHTROP

Filing Date

Jun 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HIKMA. 503B Trademark

Serial Number: 90795697 • Registration: 7634127

HIKMA. 503B is a trademark filed by Hikma Injectables USA Inc. on June 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Hikma Injectables USA Inc. (3 trademarks)

200 Connell Drive
Berkeley Heights, NJ 07922

Entity Type: 03

Trademark Details

Filing Date

June 25, 2021

Registration Date

December 31, 2024

Published for Opposition

November 1, 2022

Goods & Services

Pharmaceutical and medicinal preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders, allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders

Paper, cardboard; articles of paper or cardboard, namely, bags, envelopes, paper packaging materials, packing paper, packing cardboard, notebooks, notepads, folders, bookmarkers, calendars, boxes, coasters, stationery paper, posters, poster board, paper stationery; printed matter, namely, printed books, booklets, journals, magazines, newspapers, periodicals, pamphlets, brochures, manuals, leaflets, informational flyers, informational sheets, newsletters, and instructional worksheets all in the fields of medicine, medical technology, pharmaceuticals, and healthcare; printed instructional and teaching materials, namely, printed books, booklets, journals, magazines, newspapers, periodicals, pamphlets, brochures, manuals, leaflets, informational flyers, informational posters, informational sheets, newsletters, and instructional worksheets all in the fields of medicine, medical technology, pharmaceuticals, and healthcare; stationery; adhesive materials, namely, adhesives for stationery or household purposes, adhesive stickers, adhesive notepads

Pharmaceutical compounding services; medical testing and analysis for diagnostic or treatment purposes; genetic testing for medical purposes; advisory services relating to healthcare being medical diagnostic and treatment advisory services relating to health

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 27, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 27, 2024 CNPR
EXAMINER'S AMENDMENT ENTERED
Oct 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 27, 2024 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Oct 27, 2024 SNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 3, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 3, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 8, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 9, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 9, 2024 AITU
USE AMENDMENT FILED
Dec 20, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 20, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 26, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 26, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 26, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2021 NWOS
NEW APPLICATION ENTERED
Jun 29, 2021 NWAP